This inventor holds 1 USPTO granted patent. Top assignee: Medifron Dbt Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Jin Mi Kang
Introduction
Jin Mi Kang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compounds with therapeutic applications.
Latest Patents
Jin Mi Kang holds a patent for a compound having inhibitory activity against O-GlcNAcase. This invention relates to a novel compound that demonstrates potential in treating conditions associated with O-GlcNAcase activity.
Career Highlights
He is currently associated with Medifron Dbt Inc., where he continues to engage in innovative research and development. His work focuses on creating solutions that can have a meaningful impact on health and medicine.
Collaborations
Jin Mi Kang collaborates with talented individuals in his field, including Hee Kim and Hee Jin Ha. Their combined expertise fosters a productive environment for innovation.
Conclusion
Jin Mi Kang's contributions to biotechnology through his patent and collaborative efforts highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in therapeutic compounds.